Preparation of carbon nanotubes for biomedical applications: Size-separation and their biocompatibilities

Kazuyuki Tohji(Tohoku University), Fumio Watari(Hokkaido University), Tsukasa Akasaka(Hokkaido University), Kenichiro Shibata(Japanese Red Cross Society, Japan), Yuji Akimoto, Atsuro Yokoyama(Hokkaido University), Kazuchika Tamura(Hokkaido University), Yuta Sato, Motohiro Uo(Hokkaido University), Balachandran Jeyadevan(Tohoku University)

Unknown

December 1, 2004

Cited by 0

Related Papers

Synergistic Effect of Nod1 and Nod2 Agonists with Toll-Like Receptor Agonists on Human Dendritic Cells To Generate Interleukin-12 and T Helper Type 1 Cells

|Infection and Immunity|2005|361

Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 <i>in vitro</i> and subcutaneous tissue of rats <i>in vivo</i>

|Molecular BioSystems|2005|356

<i>Saccharomyces cerevisiae</i>‐ and <i>Candida albicans</i>‐Derived Mannan Induced Production of Tumor Necrosis Factor Alpha by Human Monocytes in a CD14‐ and Toll‐Like Receptor 4‐Dependent Manner

|Microbiology and Immunology|2002|296

Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human

|Cellular Microbiology|2004|200

Relationship between Structures and Biological Activities of Mycoplasmal Diacylated Lipopeptides and Their Recognition by Toll-Like Receptors 2 and 6

|Infection and Immunity|2004|176